Al-Karagholi, Mohammad Al-Mahdi
Peng, Kuan-Po
Petersen, Anja Sofie
De Boer, Irene
Terwindt, Gisela M.
Ashina, Messoud
Article History
Received: 6 September 2022
Accepted: 29 September 2022
First Online: 29 November 2022
Declarations
:
: MMK, KPP, ASP and IDB report no conflict of interest. GMT has received consulting fees and honoraria for lectures/presentations from Allergan, Eli Lily, Lundbeck, Novartis and Teva. Personal fees from AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva. MA participated in clinical trials as the principal investigator for AbbVie/Allergan, Amgen, Eli Lilly, Lundbeck, Novartis and Teva. MA received a research grant (institutional) from Lundbeck Foundation, Novo Nordisk Foundation, Novartis. MA has no ownership interest and does not own stocks of any pharmaceutical company. MA serves as associate editor of Cephalalgia, associate editor of the Journal of Headache and Pain, and associate editor of Brain.